Zobrazeno 1 - 5
of 5
pro vyhledávání: '"V. I. Bratko"'
Publikováno v:
Acta Biomedica Scientifica, Vol 7, Iss 1, Pp 67-73 (2022)
The aim: to conduct a clinical and diagnostic evaluation of the effectiveness of the administration of a complex of drugs in the region of hemolymphocirculation in optical neuropathy in patients with edematous form of endocrine ophthalmopathy.Materia
Externí odkaz:
https://doaj.org/article/e8a5541c38754b90b24543ca7258f868
Autor:
N. S. Arbenyeva, V. I. Bratko, G. V. Bratko, A. N. Trunov, O. V. Poveshchenko, V. V. Chernykh
Publikováno v:
Офтальмохирургия, Vol 0, Iss 2, Pp 20-25 (2020)
Purpose. To evaluate the clinical-ophthalmic effectiveness of using of autologous platelet-rich plasma as part of a comprehensive treatment regimen for uveitis associated with systemic diseases and accompanied by macular edema.Material and methods. T
Externí odkaz:
https://doaj.org/article/5785be664ff047aeaada22f4e7970819
Autor:
N. S. Arbeneva, T. A. Chekhova, V. I. Bratko, O. O. Obukhovа, O. M. Gorbenko, A. P. Shvayuk, O. V. Poveshchenko, A. N. Trunov, V. V. Chernykh
Publikováno v:
Сибирский научный медицинский журнал, Vol 39, Iss 5, Pp 110-118 (2019)
Purpose: to study the clinical and laboratory efficacy of the platelet autoplasma use in the complex treatment of endogenous uveitis associated with systemic diseases accompanied by macular edema. Material and methods. The study included 46 people (7
Externí odkaz:
https://doaj.org/article/668d7716143944d991f0abdcd3549ac7
Publikováno v:
Acta Biomedica Scientifica, Vol 4, Iss 4, Pp 83-90 (2019)
Background. A common cause of visual impairment in patients with non-infectious uveitis is macular edema, developing in 38–84 % of cases. Plasma enriched with platelets is widely used in various branches of medicine, the effectiveness of its use in
Externí odkaz:
https://doaj.org/article/6f87cfeedf4549a88239016b6eee9d43
Publikováno v:
Acta Biomedica Scientifica, Vol 4, Iss 4, Pp 134-138 (2019)
Background. Lack of a holistic understanding of the etiology and pathogenesis of central serous chorioretinopathy (CSH), which determines the conduct of pathogenetic therapy, as well as the lack of effectiveness of treatment methods aimed at developi
Externí odkaz:
https://doaj.org/article/824aa70dbb1c467dbe41ff718d5e6034